Novo Nordisk A/S shares rose to the highest level in more than two months after a report that activist hedge fund Parvus Asset Management has built a stake as the Danish drugmaker struggles to keep its lead in the obesity market.
Novo Climbs After FT Reports Activist Parvus Amassed Stake
Date:


